Trajan is a biotech company that develops and commercializes technologies that enable analytical systems.
Trajan has raised $20.9M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2022.
Trajan is headquartered in Ringwood, Australia.
Trajan is a biotech company that develops and commercializes technologies that enable analytical systems.
Trajan is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Trajan — Funding & Investors." VCBacked, June 16, 2022, https://www.vcbacked.co/company/trajan. Accessed August 14, 2026.
VCBacked. (2022). Trajan — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/trajan
{{cite web |title=Trajan — Funding & Investors |url=https://www.vcbacked.co/company/trajan |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated